
### [NCIT:C134154](http://purl.obolibrary.org/obo/NCIT_C134154)
**Label:** Refractory Lymphoma

**Subclasses:** [NCIT:C4997](http://purl.obolibrary.org/obo/NCIT_C4997) (Refractory Nodal Marginal Zone Lymphoma), [NCIT:C8938](http://purl.obolibrary.org/obo/NCIT_C8938) (Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma), [NCIT:C8836](http://purl.obolibrary.org/obo/NCIT_C8836) (Refractory Hodgkin Lymphoma), [NCIT:C8858](http://purl.obolibrary.org/obo/NCIT_C8858) (Refractory Follicular Lymphoma), [NCIT:C115458](http://purl.obolibrary.org/obo/NCIT_C115458) (Refractory Childhood Hodgkin Lymphoma), [NCIT:C7227](http://purl.obolibrary.org/obo/NCIT_C7227) (Refractory T Lymphoblastic Lymphoma), [NCIT:C8658](http://purl.obolibrary.org/obo/NCIT_C8658) (Refractory Anaplastic Large Cell Lymphoma), [NCIT:C7228](http://purl.obolibrary.org/obo/NCIT_C7228) (Refractory Mature B-Cell Non-Hodgkin Lymphoma), [NCIT:C8833](http://purl.obolibrary.org/obo/NCIT_C8833) (Refractory Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C8853](http://purl.obolibrary.org/obo/NCIT_C8853) (Refractory Diffuse Large B-Cell Lymphoma), [NCIT:C8875](http://purl.obolibrary.org/obo/NCIT_C8875) (Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8652](http://purl.obolibrary.org/obo/NCIT_C8652) (Refractory Lymphoplasmacytic Lymphoma), [NCIT:C138014](http://purl.obolibrary.org/obo/NCIT_C138014) (Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma), [NCIT:C8650](http://purl.obolibrary.org/obo/NCIT_C8650) (Refractory Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C8870](http://purl.obolibrary.org/obo/NCIT_C8870) (Refractory B Lymphoblastic Lymphoma), [NCIT:C8671](http://purl.obolibrary.org/obo/NCIT_C8671) (Refractory Angioimmunoblastic T-cell Lymphoma), [NCIT:C5090](http://purl.obolibrary.org/obo/NCIT_C5090) (Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C8927](http://purl.obolibrary.org/obo/NCIT_C8927) (Refractory Centroblastic Lymphoma), [NCIT:C8847](http://purl.obolibrary.org/obo/NCIT_C8847) (Refractory Burkitt Lymphoma), [NCIT:C8669](http://purl.obolibrary.org/obo/NCIT_C8669) (Refractory Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C8846](http://purl.obolibrary.org/obo/NCIT_C8846) (Refractory Small Lymphocytic Lymphoma), [NCIT:C138028](http://purl.obolibrary.org/obo/NCIT_C138028) (Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type), [NCIT:C8689](http://purl.obolibrary.org/obo/NCIT_C8689) (Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma), [NCIT:C8701](http://purl.obolibrary.org/obo/NCIT_C8701) (Refractory Non-Hodgkin Lymphoma), [NCIT:C9339](http://purl.obolibrary.org/obo/NCIT_C9339) (Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified), [NCIT:C8687](http://purl.obolibrary.org/obo/NCIT_C8687) (Refractory Mycosis Fungoides), [NCIT:C138024](http://purl.obolibrary.org/obo/NCIT_C138024) (Refractory Breast Lymphoma), [NCIT:C8842](http://purl.obolibrary.org/obo/NCIT_C8842) (Refractory B-Cell Non-Hodgkin Lymphoma), [NCIT:C8664](http://purl.obolibrary.org/obo/NCIT_C8664) (Refractory T-Cell Non-Hodgkin Lymphoma), [NCIT:C8862](http://purl.obolibrary.org/obo/NCIT_C8862) (Refractory Mantle Cell Lymphoma), [NCIT:C138026](http://purl.obolibrary.org/obo/NCIT_C138026) (Refractory Intravascular Large B-Cell Lymphoma), [NCIT:C138020](http://purl.obolibrary.org/obo/NCIT_C138020) (Refractory Central Nervous System Lymphoma), [NCIT:C5096](http://purl.obolibrary.org/obo/NCIT_C5096) (Refractory Splenic Marginal Zone Lymphoma), [NCIT:C8681](http://purl.obolibrary.org/obo/NCIT_C8681) (Refractory Enteropathy-Associated T-Cell Lymphoma), [NCIT:C138022](http://purl.obolibrary.org/obo/NCIT_C138022) (Refractory Testicular Lymphoma), [NCIT:C7260](http://purl.obolibrary.org/obo/NCIT_C7260) (Refractory Nodular Lymphocyte Predominant Hodgkin Lymphoma), [NCIT:C133736](http://purl.obolibrary.org/obo/NCIT_C133736) (Refractory Classical Hodgkin Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 52.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39825](http://purl.obolibrary.org/obo/NCIT_C39825) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39821](http://purl.obolibrary.org/obo/NCIT_C39821) (Infiltrating Bladder Lymphoepithelioma-Like Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39820](http://purl.obolibrary.org/obo/NCIT_C39820) (Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39819](http://purl.obolibrary.org/obo/NCIT_C39819) (Infiltrating Bladder Urothelial Carcinoma, Nested Variant))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39818](http://purl.obolibrary.org/obo/NCIT_C39818) (Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39817](http://purl.obolibrary.org/obo/NCIT_C39817) (Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39816](http://purl.obolibrary.org/obo/NCIT_C39816) (Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39815](http://purl.obolibrary.org/obo/NCIT_C39815) (Cellular Congenital Mesoblastic Nephroma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39814](http://purl.obolibrary.org/obo/NCIT_C39814) (Classic Congenital Mesoblastic Nephroma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39813](http://purl.obolibrary.org/obo/NCIT_C39813) (SMARCB1 Gene Inactivation))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39812](http://purl.obolibrary.org/obo/NCIT_C39812) (Metanephric Adenofibroma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39811](http://purl.obolibrary.org/obo/NCIT_C39811) (t(5;11)(q35;q13)))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39810](http://purl.obolibrary.org/obo/NCIT_C39810) (Type 2 Renal Papillary Adenoma))) 40.36%


